Cargando…

Assessing oral glucose and intravenous insulin loading protocol in (18)F-fluorodeoxyglucose positron emission tomography cardiac viability studies

Oral glucose and intravenous insulin (G/I) loading protocols are commonly used in (18)F-fluorodeoxyglucose (FDG) positron emission tomography (PET) cardiac viability studies. Although the amount of insulin to be given per blood glucose range has been well described in guidelines, the amount of gluco...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarikaya, Ismet, Sharma, Prem N., Sarikaya, Ali, Elgazzar, Abdelhamid H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7067136/
https://www.ncbi.nlm.nih.gov/pubmed/32190015
http://dx.doi.org/10.4103/wjnm.WJNM_58_18
_version_ 1783505354267557888
author Sarikaya, Ismet
Sharma, Prem N.
Sarikaya, Ali
Elgazzar, Abdelhamid H.
author_facet Sarikaya, Ismet
Sharma, Prem N.
Sarikaya, Ali
Elgazzar, Abdelhamid H.
author_sort Sarikaya, Ismet
collection PubMed
description Oral glucose and intravenous insulin (G/I) loading protocols are commonly used in (18)F-fluorodeoxyglucose (FDG) positron emission tomography (PET) cardiac viability studies. Although the amount of insulin to be given per blood glucose range has been well described in guidelines, the amount of glucose to be given is not detailed well. In this retrospective study, we aimed to assess if certain parameters, particularly the amount of glucose and insulin given, may affect (18)F-FDG uptake in the hibernating myocardium and also determine the problems with this protocol. (18)F-FDG PET cardiac viability study with G/I loading protocols was performed in 49 patients. Fasting blood glucose (FBG), amount of glucose given, blood glucose level after glucose load, amount of insulin given, and blood glucose level at the time of (18)F-FDG injection were recorded. Statistical analysis was performed to determine if there is any difference in the above values in PET viable and PET nonviable groups and also in subgroups assessing (18)F-FDG uptake also in normal myocardium. For G/I loading, we used our local protocol in 43 patients, and other protocols in six. (18)F-FDG PET showed viability in 31 patients, and it was negative for viability in 18. In 22 patients, mainly in PET viable group, there was varying degree of reduced (18)F-FDG uptake in normal myocardium. There was no significant difference in FBG, amount of glucose given, blood glucose level after glucose load, amount of insulin given, and blood glucose level at the time of (18)F-FDG injection in PET viable and PET nonviable groups and also in subgroups. The problems with G/I loading protocol included deciding on the amounts of glucose and insulin given, maximum amount of insulin to be given, handling diabetics, optimal time to measure blood glucose after insulin administration, and interpretation of findings in cases with diffusely reduced (18)F-FDG uptake. Further improvements in current guidelines are necessary to obtain images in optimal conditions for accurate results.
format Online
Article
Text
id pubmed-7067136
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-70671362020-03-18 Assessing oral glucose and intravenous insulin loading protocol in (18)F-fluorodeoxyglucose positron emission tomography cardiac viability studies Sarikaya, Ismet Sharma, Prem N. Sarikaya, Ali Elgazzar, Abdelhamid H. World J Nucl Med Original Article Oral glucose and intravenous insulin (G/I) loading protocols are commonly used in (18)F-fluorodeoxyglucose (FDG) positron emission tomography (PET) cardiac viability studies. Although the amount of insulin to be given per blood glucose range has been well described in guidelines, the amount of glucose to be given is not detailed well. In this retrospective study, we aimed to assess if certain parameters, particularly the amount of glucose and insulin given, may affect (18)F-FDG uptake in the hibernating myocardium and also determine the problems with this protocol. (18)F-FDG PET cardiac viability study with G/I loading protocols was performed in 49 patients. Fasting blood glucose (FBG), amount of glucose given, blood glucose level after glucose load, amount of insulin given, and blood glucose level at the time of (18)F-FDG injection were recorded. Statistical analysis was performed to determine if there is any difference in the above values in PET viable and PET nonviable groups and also in subgroups assessing (18)F-FDG uptake also in normal myocardium. For G/I loading, we used our local protocol in 43 patients, and other protocols in six. (18)F-FDG PET showed viability in 31 patients, and it was negative for viability in 18. In 22 patients, mainly in PET viable group, there was varying degree of reduced (18)F-FDG uptake in normal myocardium. There was no significant difference in FBG, amount of glucose given, blood glucose level after glucose load, amount of insulin given, and blood glucose level at the time of (18)F-FDG injection in PET viable and PET nonviable groups and also in subgroups. The problems with G/I loading protocol included deciding on the amounts of glucose and insulin given, maximum amount of insulin to be given, handling diabetics, optimal time to measure blood glucose after insulin administration, and interpretation of findings in cases with diffusely reduced (18)F-FDG uptake. Further improvements in current guidelines are necessary to obtain images in optimal conditions for accurate results. Wolters Kluwer - Medknow 2020-02-27 /pmc/articles/PMC7067136/ /pubmed/32190015 http://dx.doi.org/10.4103/wjnm.WJNM_58_18 Text en Copyright: © 2020 World Journal of Nuclear Medicine http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Sarikaya, Ismet
Sharma, Prem N.
Sarikaya, Ali
Elgazzar, Abdelhamid H.
Assessing oral glucose and intravenous insulin loading protocol in (18)F-fluorodeoxyglucose positron emission tomography cardiac viability studies
title Assessing oral glucose and intravenous insulin loading protocol in (18)F-fluorodeoxyglucose positron emission tomography cardiac viability studies
title_full Assessing oral glucose and intravenous insulin loading protocol in (18)F-fluorodeoxyglucose positron emission tomography cardiac viability studies
title_fullStr Assessing oral glucose and intravenous insulin loading protocol in (18)F-fluorodeoxyglucose positron emission tomography cardiac viability studies
title_full_unstemmed Assessing oral glucose and intravenous insulin loading protocol in (18)F-fluorodeoxyglucose positron emission tomography cardiac viability studies
title_short Assessing oral glucose and intravenous insulin loading protocol in (18)F-fluorodeoxyglucose positron emission tomography cardiac viability studies
title_sort assessing oral glucose and intravenous insulin loading protocol in (18)f-fluorodeoxyglucose positron emission tomography cardiac viability studies
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7067136/
https://www.ncbi.nlm.nih.gov/pubmed/32190015
http://dx.doi.org/10.4103/wjnm.WJNM_58_18
work_keys_str_mv AT sarikayaismet assessingoralglucoseandintravenousinsulinloadingprotocolin18ffluorodeoxyglucosepositronemissiontomographycardiacviabilitystudies
AT sharmapremn assessingoralglucoseandintravenousinsulinloadingprotocolin18ffluorodeoxyglucosepositronemissiontomographycardiacviabilitystudies
AT sarikayaali assessingoralglucoseandintravenousinsulinloadingprotocolin18ffluorodeoxyglucosepositronemissiontomographycardiacviabilitystudies
AT elgazzarabdelhamidh assessingoralglucoseandintravenousinsulinloadingprotocolin18ffluorodeoxyglucosepositronemissiontomographycardiacviabilitystudies